Literature DB >> 9086393

Hematological impairments in recurrent Plasmodium vivax infected patients.

R Selvam1, G Baskaran.   

Abstract

The hematological parameters were assayed in Plasmodium vivax patients with only one infection, two infections, three infections and more than three malarial infections during a period of six months. A steady fall in the levels of hemoglobin as well as packed cell volume (PVC) level was observed with increasing number of infections. The malarial patients showed a progressive decrease in RBC level with increasing number of attacks. The decrease in the hematological indices was statistically significant at all levels of parasitemia. There was a marked increase in the osmotic fragility of the malarial erythrocytes when compared to that of controls. During repeated malarial attacks, significant decrease in MCH (p < 0.05) and MCH (p < 0.01) and increase in the MCV level (p < 0.05) and Heinz body formation (p < 0.001) were observed. Parasite density significantly influenced the fragility of the erythrocytes, Heinz body formation, MCV, MCH and MCHC levels. Thus, the erythrocytes of the patients repeatedly infected with Plasmodium vivax parasite are subjected to structural and functional impairment, ultimately culminating in anemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9086393     DOI: 10.7883/yoken1952.49.151

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  7 in total

1.  Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin.

Authors:  Tasanee Panichakul; Saranyoo Ponnikorn; Sittiruk Roytrakul; Atchara Paemanee; Suthathip Kittisenachai; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2015-03-31       Impact factor: 2.979

Review 2.  ICU management of severe malaria.

Authors:  D Gupta; K Chugh; A Sachdev; A Soni
Journal:  Indian J Pediatr       Date:  2001-11       Impact factor: 1.967

Review 3.  The anaemia of Plasmodium vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Pierre A Buffet; Jeanne R Poespoprodjo; Tsin W Yeo; Nicholas J White; Ric N Price
Journal:  Malar J       Date:  2012-04-27       Impact factor: 2.979

4.  Suppression of erythroid development in vitro by Plasmodium vivax.

Authors:  Tasanee Panichakul; Witchuda Payuhakrit; Panyu Panburana; Chokdee Wongborisuth; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2012-05-24       Impact factor: 2.979

5.  Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.

Authors:  Nicholas M Douglas; Daniel A Lampah; Enny Kenangalem; Julie A Simpson; Jeanne R Poespoprodjo; Paulus Sugiarto; Nicholas M Anstey; Ric N Price
Journal:  PLoS Med       Date:  2013-12-17       Impact factor: 11.069

6.  Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya.

Authors:  Paul Kosiyo; Walter Otieno; Jesse Gitaka; Elly O Munde; Collins Ouma
Journal:  BMC Infect Dis       Date:  2020-11-25       Impact factor: 3.090

7.  Direct and indirect costs of co-infection in the wild: Linking gastrointestinal parasite communities, host hematology, and immune function.

Authors:  Sarah A Budischak; Anna E Jolles; Vanessa O Ezenwa
Journal:  Int J Parasitol Parasites Wildl       Date:  2012-11-02       Impact factor: 2.674

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.